The inflammation continues its work unchecked
Brazil's SUS data shows 15% annual growth in IBD prevalence, reaching 100 cases per 100,000 inhabitants, affecting approximately 10 million people globally. Late diagnosis remains critical challenge as symptoms mimic common digestive issues; untreated inflammation increases colorectal cancer risk after 8-10 years.
- 15% annual increase in inflammatory bowel disease cases in Brazil's public health system
- 100 cases per 100,000 inhabitants; approximately 10 million people affected globally
- Crohn's disease can affect entire digestive tract; ulcerative colitis affects only colon and rectum
- Active inflammation lasting 8-10+ years significantly increases colorectal cancer risk
- Surge concentrated among young people aged 15-40
Brazil reports a 15% annual increase in inflammatory bowel disease cases, with Crohn's disease and ulcerative colitis advancing among youth aged 15-40, driven by modern lifestyle factors and delayed diagnosis.
Doctors across Brazil and beyond are watching a troubling trend take shape. Cases of inflammatory bowel disease—a category that includes Crohn's disease and ulcerative colitis—are climbing at a rate that has alarmed the medical establishment. The numbers tell the story: roughly ten million people worldwide now live with these conditions, and in Brazil specifically, a study drawing from more than 212,000 patient records in the public health system found the diseases advancing at an average rate of fifteen percent each year. The prevalence has reached one hundred cases per one hundred thousand inhabitants, a figure that reflects not just individual suffering but a genuine shift in the disease landscape.
The two main inflammatory bowel diseases operate differently, though their symptoms often blur together in ways that confound diagnosis. Crohn's disease can strike anywhere along the digestive tract—from the mouth all the way to the anus—while ulcerative colitis confines itself to the colon and rectum. This distinction matters for treatment, but it matters less to the patient experiencing the early warning signs, which look deceptively ordinary. A bout of stomach pain after a heavy meal, a few days of diarrhea from a passing virus—these are the kinds of things people dismiss and move on from. But when diarrhea persists for weeks, when blood or mucus appears in the stool, when weight drops without explanation and fatigue becomes a constant companion, something else is happening. These are the red flags that demand investigation, yet they are precisely the symptoms that get mistaken for common digestive troubles.
Gastroenterologist Sandro Andrade, speaking to the newspaper, identified late diagnosis as one of the field's most pressing challenges. The confusion is understandable but costly. A temporary stomach upset resolves on its own in days. Crohn's disease and ulcerative colitis are chronic and recurring—they do not go away, and they do not improve without intervention. When patients delay seeking proper medical attention, the inflammation continues its work unchecked. Over time, this can lead to intestinal blockages, fistulas, and abscesses that demand hospitalization and emergency surgery. The stakes climb higher still: medical organizations both in Brazil and internationally have documented that patients with active inflammation lasting eight to ten years or longer face a significantly elevated risk of colorectal cancer.
The good news, Andrade explained, is that treatment has evolved. The current global approach, called Treat-to-Target, aims for complete healing of the intestinal lining while keeping patients in sustained remission and free from corticosteroid dependence. This represents a meaningful shift from older strategies that merely managed symptoms. But prevention and early detection remain the stronger hand. Experts have begun connecting the rise in these diseases to the texture of modern life itself. Young people aged fifteen to forty are being diagnosed at increasing rates, and the pattern points toward lifestyle factors: the prevalence of ultraprocessed foods loaded with sugar and fat, the chronic stress that has become ambient in contemporary society, the sleep deprivation that so many accept as normal. These conditions create an environment in which inflammatory bowel disease takes root and spreads.
As May—designated Purple May by health organizations to raise awareness—unfolds, medical professionals are pushing a simple message: watch for the warning signs, seek diagnosis early, and maintain specialized care. The difference between catching these diseases in their early stages and discovering them after years of silent damage is the difference between managing a chronic condition and facing emergency surgery, between a life with manageable constraints and one interrupted by serious complications. The surge is real, the risks are documented, and the window for intervention remains open—but only for those who recognize what they are seeing.
Citações Notáveis
Temporary stomach upset resolves on its own in days. Crohn's disease and ulcerative colitis are chronic and recurring—they do not go away without intervention.— Gastroenterologist Sandro Andrade
The current global approach aims for complete healing of the intestinal lining while keeping patients in sustained remission and free from corticosteroid dependence.— Sandro Andrade, describing the Treat-to-Target strategy
A Conversa do Hearth Outra perspectiva sobre a história
Why are these diseases showing up so much more often now than they did, say, twenty years ago?
The doctors point to how we live. Ultraprocessed foods, constant stress, not sleeping enough—these things seem to create the conditions where inflammatory bowel disease takes hold. It's not that the disease is new, but the modern environment appears to be feeding it.
But couldn't it just be that we're better at diagnosing it now?
That's part of it, certainly. Better awareness, more testing. But the data from Brazil's public health system shows a fifteen percent annual increase—that's steep enough that improved diagnosis alone doesn't explain it. Something in how people are living is genuinely changing the disease landscape.
What happens if someone ignores the symptoms for years?
That's where it gets serious. The inflammation keeps working. You can develop blockages in the intestines, fistulas, abscesses. You end up needing emergency surgery. And if the inflammation stays active for eight to ten years, your risk of colorectal cancer climbs significantly.
So early diagnosis is really the difference between manageable and catastrophic?
Exactly. Catch it early, treat it properly with the newer strategies—the ones aimed at actually healing the intestinal lining—and you can live a fairly normal life. Miss it, let it simmer for years, and you're looking at surgeries, complications, cancer risk.
Who's most at risk right now?
Young people, mainly between fifteen and forty. That's where the surge is happening. They're the ones eating the processed foods, living with the stress, not sleeping. Their bodies are bearing the weight of modern life in a very literal way.